Compound Detail

CHEMBL190617

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CCc1c2c(nc3ccc4c(c13)CC(C)O4)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL190617
Phase	Preclinical
Structure Type	MOL
InChI Key	KRFSBASBXJUKNW-CLCOAUNSSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

432.5

MW (Da)

2.97

ALogP

HBA

HBD

90.7

PSA (Å²)

0.49

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 8.59

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
Unchecked CHEMBL612545	IC50	8.59	8.155	2.6	2
HL-60 CHEMBL383	IC50	8.31	8.31	4.9	1
Bel-7402 CHEMBL614279	IC50	8.12	8.12	7.5	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
Unchecked	IC50	=	2.6	nM	8.59	In-vitro inhibitory concentration for human tumor HCT116 cell-line was determine...	15913996
HL-60	IC50	=	4.9	nM	8.31	In-vitro inhibitory concentration for human tumor HL60 cell-line was determined ...	15913996
Bel-7402	IC50	=	7.5	nM	8.12	In-vitro inhibitory concentration for human tumor BEL-7402 cell-line was determi...	15913996
Unchecked	IC50	=	19.0	nM	7.72	In-vitro inhibitory concentration for human tumor HELA cell-line was determined ...	15913996

PubMed	DOI	Target Context	# Activities
15913996	10.1016/j.bmcl.2005.04.063	Unchecked	2
15913996	10.1016/j.bmcl.2005.04.063	HL-60	1
15913996	10.1016/j.bmcl.2005.04.063	Bel-7402	1

Data from ChEMBL 36 via Core Engine